Law, C.H. and Kiew, L.V. and Abdullah, N.A. and Abdul Sattar, M. and Abdul Rahman, N. and Khan, A.H. and Johns, E.J. (2008) Effect of TGF-β1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats. Acta Pharmacologica Sinica, 29 (4). pp. 451-457. ISSN 0253-9756, DOI https://doi.org/10.1111/j.1745-7254.2008.00772.x.
![[img]](http://eprints.um.edu.my/style/images/fileicons/application_msword.png) |
Microsoft Word
Kiew_LV_2008.docx Download (16kB) |
Abstract
AIM: The aim of the present study was to investigate the effectiveness of transforming growth factor (TGF)-beta1 antisense oligodeoxynucleotides (ODN) in ameliorating deteriorated kidney function in rats with puromycin-induced chronic renal failure (CRF). METHODS: Saline, puromycin, puromycin+TGF-beta1 antisense ODN or puromycin+scrambled ODN were administered to unilaterally nephrectomized rats. Renal hemodynamic and excretory measurements were taken in the anaesthetized rats that had undergone surgical procedure. RESULTS: It was observed that in the CRF rats, there was a marked reduction in the renal blood flow (RBF), glomerular filtration rate (GFR), severe proteinuria, and almost 6-fold increased fractional excretion of sodium (FE Na+) as compared to that in the control rats (all P<0.05). It was further observed that in the CRF rats, the treatment with TGF-beta1 antisense, but not scrambled ODN, markedly attenuated the reduction of RBF, GFR, and proteinuria and markedly prevented the increase of the FE Na+ (all P<0.05). In addition, the renal hypertrophy in the CRF group (P<0.05 vs non-renal failure control) was markedly attenuated after treatment with TGF-1 antisense ODN (P<0.05). Focal segmental glomerulosclerosis was evident only in the untreated and scrambled ODN-treated CRF groups. An interesting observation of this study was that in the CRF rats, although there was marked attenuating and preventive effects of the TGF-beta1 antisense ODN on the deteriorated renal functions, the antisense treatment did not cause any marked change in the renal expression of TGF-beta1 at the protein level. CONCLUSION: Collectively, the data obtained suggests that TGF-beta1 antisense ODN possesses beneficial effects in puromycininduced chronic renal failure and that the deterioration in morphology and impaired renal function in this pathological state is in part dependent upon the action of TGF-beta1 within the kidney.
| Item Type: | Article |
|---|---|
| Funders: | UNSPECIFIED |
| Additional Information: | Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia |
| Uncontrolled Keywords: | Animals, Glomerular Filtration Rate/Drug Effects, Inulin/Blood, Kidney/Blood Supply/Drug Effects/*Metabolism/Pathology, Kidney Failure, Chronic/Chemically Induced/*Physiopathology, Male, Nephrectomy, Nephritis, Interstitial/Metabolism/Pathology, Oligonucleotides, Antisense/*Pharmacology, Organ Size/Drug Effects, Proteinuria/Metabolism/Pathology, Puromycin/Toxicity, Rats, Inbred Wky, Regional Blood Flow/Drug Effects, Transforming Growth Factor Beta1/*Genetics/Metabolism |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RB Pathology R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica |
| Divisions: | Faculty of Medicine |
| Depositing User: | Dr. Lik Voon Kiew |
| Date Deposited: | 14 Feb 2012 01:57 |
| Last Modified: | 11 Nov 2013 01:13 |
| URI: | http://eprints.um.edu.my/id/eprint/2640 |
Actions (login required)
 |
View Item |
